Treating brain tumor – A new approach to cancer treatment

Treating brain tumor in India is done with high level of expertise & new approach using latest technology by trained neurosurgeons. Connect with +91 96 1588 1588 to know details of brain tumor surgery, treatment & cost in India.

Share This Post

Treating brain tumor involves high level of expertise and new approach with latest technology & medicines is required to effectively combat this deadly disease. A new study and approach to cancer treatment shows targeting body biological clock. Two compounds that targets the elements of circadian clock destroys several kinds of cancer cells in the laboratory and slowed the growth of brain tumor in mice without having any impact on normal cells.

The Circadian Clock

The circadian clock is a complex natural hardware that controls the every day musicality of human body, for example, rest, body temperature, and assimilation. The ace “clock” is a zone in the cerebrum that faculties ecological prompts, (for example, light) and conveys data to auxiliary checks in different organs.
Moreover, every cell in the body contains its very own clock that controls the day by day swaying of numerous cell capacities. All checks in the body are for the most part in a state of harmony, enabling the life form to adjust to its condition and keep up a natural equalization.

REV-ERB proteins are key segments of the clock hardware that subdue natural capacities that disease cells rely upon, for example, cell division and cell digestion. So Dr. Panda and his partners chose to explore whether intensifies that actuate REV-ERBs (known as REV-ERB agonists) may probably execute malignant growth cells by blocking capacities they have to keep developing.

In lab tries, the analysts found that two REV-ERB agonists murdered diverse kinds of malignancy cells (counting mind, colon, and bosom), despite the fact that the cells had distinctive hereditary transformations that drive disease development. The REV-ERB agonists did not murder solid mind or skin cells, be that as it may.
These discoveries recommend that medicates that actuate REV-ERBs conceivably could be utilized to treat a wide range of kinds of malignancy, the analysts clarified.

Researchers are creating drugs that initiate or curb other circadian clock parts, and it is conceivable that blends of various clock-focusing on medications or of clock-focusing on medications with different kinds of treatment may improve anticancer impacts. In any case, right now, there are a larger number of inquiries than there are answers.

For brain tumor treatment and surgery connect with us at +91 96 1588 1588. Or email your reports at cancerfax@gmail.com for free consultation.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy